Iron, radiation, and cancer.

Increased iron content of cells and tissue may increase the risk of cancer. In particular, high available iron status may increase the risk of a radiation-induced cancer. There are two possible mechanisms for this effect: iron can catalyze the production of oxygen radicals, and it may be a limiting nutrient to the growth and development of a transformed cell in vivo. Given the high available iron content of the western diet and the fact that the world is changing to the western model, it is important to determine if high iron increases the risk of cancer.

[1]  D. Harman.  Free‐Radical Theory of Aging , 1992, Mutation research.

[2]  E. Weinberg.  IRON, ASBESTOS, AND CARCINOGENICITY , 1989, The Lancet.

[3]  E. Wiener.  Bone sarcomas linked to radiotherapy and chemotherapy in children , 1988 .

[4]  M. Stahlhut,et al.  Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. , 1988, Cancer research.

[5]  W T Kaune,et al.  Acute nonlymphocytic leukemia and residential exposure to power frequency magnetic fields. , 1988, American journal of epidemiology.

[6]  S. Linn,et al.  DNA damage and oxygen radical toxicity. , 1988, Science.

[7]  B. Ames,et al.  Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxides in bile. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Ames,et al.  Oxygen radicals and human disease. , 1987, Annals of internal medicine.

[9]  R. Brown,et al.  The role of catalytic iron in asbestos induced lipid peroxidation and DNA-strand breakage in C3H10T1/2 cells. , 1987, British Journal of Cancer.

[10]  K. McLeod,et al.  Frequency dependence of electric field modulation of fibroblast protein synthesis. , 1987, Science.

[11]  P. Henson,et al.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. , 1987, The Journal of clinical investigation.

[12]  R. Doll,et al.  Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. , 1987, British Journal of Cancer.

[13]  M. M. Elkind,et al.  Promotion, dose rate, and repair processes in radiation-induced neoplastic transformation. , 1987, Radiation research.

[14]  R. Weinberg,et al.  Blood-letting, iron homeostasis, and human health. , 1986, Medical hypotheses.

[15]  R. Brookmeyer,et al.  Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. , 1986, The New England journal of medicine.

[16]  T. Shiga,et al.  Product yield of magnetic-field-dependent photochemical reaction modulated by electron spin resonance , 1986, Nature.

[17]  R. Buschbom,et al.  Influence of iron on plutonium absorption by the adult and neonatal rat. , 1986, Toxicology and applied pharmacology.

[18]  J. Brock.  Iron and the outcome of infection. , 1986, British medical journal.

[19]  G. P. Jacobs,et al.  Radiosensitization by diamide analogs and arsenicals. , 1986, International journal of radiation oncology, biology, physics.

[20]  M. Stratford,et al.  Glutathione-reactive nitro compounds as radiosensitizers: mechanistic and therapeutic implications. , 1986, International journal of radiation oncology, biology, physics.

[21]  Y. Shibamoto,et al.  Radiosensitization in vitro and in vivo by 3-nitrotriazoles. , 1986, International journal of radiation oncology, biology, physics.

[22]  C. Koch,et al.  Combined radiation-protective and radiation-sensitizing agents. III: Radiosensitization by misonidazole as a function of concentrations of endogenous glutathione or exogenous thiols. , 1986, International journal of radiation oncology, biology, physics.

[23]  N. Farrell,et al.  A new ruthenium radiosensitizer: RuCl2(DMSO)2(4-nitroimidazole)2. , 1986, International journal of radiation oncology, biology, physics.

[24]  T. C. Jenkins,et al.  The phosphate-group of DNA as a potential target for RSU-1069, a nitroimidazole-aziridine radiosensitizer. , 1986, International journal of radiation oncology, biology, physics.

[25]  J. Boivin,et al.  Leukemia after radiotherapy for first primary cancers of various anatomic sites. , 1986, American journal of epidemiology.

[26]  Richard C. Miller,et al.  Paraquat induced radiosensitization of mammalian cells. , 1986, Journal of radiation research.

[27]  D. Addy.  Happiness is: iron , 1986, British medical journal.

[28]  B. Halliwell,et al.  Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. , 1986, Archives of biochemistry and biophysics.

[29]  R. Stevens.  Age and risk of acute leukemia. , 1986, Journal of the National Cancer Institute.

[30]  D. Deen,et al.  Double elution analysis of cross-link formation and repair in cycling and noncycling 9L spheroid cells. , 1986, Cancer research.

[31]  J. Mendelsohn,et al.  Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies. , 1986, Cancer research.

[32]  R. Stevens,et al.  Iron-binding proteins and risk of cancer in Taiwan. , 1986, Journal of the National Cancer Institute.

[33]  J. Zwiller,et al.  Iron-induced L1210 cell growth: evidence of a transferrin-independent iron transport. , 1986, Cancer research.

[34]  C. Borek,et al.  Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Young,et al.  Intracellular processing of transferrin and iron by isolated rat hepatocytes. , 1985, The Biochemical journal.

[36]  B. Carnes,et al.  Protective effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid against induction of altered hepatocyte foci in rats treated once with gamma-radiation within one day after birth. , 1985, Cancer research.

[37]  K. Mossman,et al.  Radiosensitization of human fibroblasts by 3-aminobenzamide: an inhibitor of poly(ADP-ribosylation). , 1985, Radiation research.

[38]  R. Bergeron,et al.  Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II. , 1985, Cancer research.

[39]  J. Ward,et al.  Mammalian cells are not killed by DNA single-strand breaks caused by hydroxyl radicals from hydrogen peroxide. , 1985, Radiation research.

[40]  J. Eaton,et al.  Dietary suppression of colonic cancer fiber or phytate? , 1985, Cancer.

[41]  M. O'Connell,et al.  The role of iron in ferritin- and haemosiderin-mediated lipid peroxidation in liposomes. , 1985, The Biochemical journal.

[42]  E. Balcer-Kubiczek,et al.  Evidence for microwave carcinogenesis in vitro. , 1985, Carcinogenesis.

[43]  M. Edgren,et al.  Combined effect of misonidazole and glutathione depletion by buthionine sulphoximine on cellular radiation response. , 1985, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[44]  J. Fowler,et al.  Eighth annual Juan del Regato lecture. Chemical modifiers of radiosensitivity--theory and reality: a review. , 1985, International journal of radiation oncology, biology, physics.

[45]  R. Bergeron,et al.  Influence of iron on in vivo proliferation and lethality of L1210 cells. , 1985, The Journal of nutrition.

[46]  P. Cerutti.  Prooxidant states and tumor promotion. , 1985, Science.

[47]  T. Ono,et al.  Unique increase of superoxide dismutase level in brains of long living mammals , 1984, Experimental Gerontology.

[48]  S. Marklund,et al.  Radiation resistance and the CuZn superoxide dismutase, Mn superoxide dismutase, catalase, and glutathione peroxidase activities of seven human cell lines. , 1984, Radiation research.

[49]  M. Chung,et al.  Stucture and function of transferrin , 1984 .

[50]  D. Shrieve,et al.  Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro. , 1984, Radiation research.

[51]  K. Skov.  The contribution of hydroxyl radical to radiosensitization: a study of DNA damage. , 1984, Radiation research.

[52]  K. Neriishi,et al.  Endotoxin treatment protects vitamin E-deficient rats from pulmonary O2 toxicity. , 1984, The American journal of physiology.

[53]  M. Anderson,et al.  Radioprotection by glutathione ester: transport of glutathione ester into human lymphoid cells and fibroblasts. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. J. Reed,et al.  Glutathione depletion and susceptibility. , 1984, Pharmacological reviews.

[55]  K. Konopka,et al.  Effect of serum albumin on siderophore-mediated utilization of transferrin iron. , 1984, Biochemistry.

[56]  R. Meneghini,et al.  Correlation between cytotoxic effect of hydrogen peroxide and the yield of DNA strand breaks in cells of different species. , 1984, Biochimica et biophysica acta.

[57]  B. Halliwell,et al.  Oxygen toxicity, oxygen radicals, transition metals and disease. , 1984, The Biochemical journal.

[58]  B. Hankey,et al.  Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience. , 1984, Journal of the National Cancer Institute.

[59]  H. Stokinger.  A review of world literature finds iron oxides noncarcinogenic. , 1984, American Industrial Hygiene Association journal.

[60]  Jonathan Scott Friedlaender,et al.  Iron-binding proteins, hepatitis B virus, and mortality in the Solomon Islands. , 1983, American journal of epidemiology.

[61]  B. Ames,et al.  Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. , 1983, Science.

[62]  R. Floyd,et al.  Direct demonstration that ferrous ion complexes of di- and triphosphate nucleotides catalyze hydroxyl free radical formation from hydrogen peroxide. , 1983, Archives of biochemistry and biophysics.

[63]  P. Harrison,et al.  Effect of ferritin-containing fractions with different iron loading on lipid peroxidation. , 1983, The Biochemical journal.

[64]  S. Latt,et al.  Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells. , 1983, The New England journal of medicine.

[65]  C. Greenstock.  THE ROLE OF FREE RADICALS IN RADIATION AND CHEMICAL CARCINOGENESIS , 1982 .

[66]  J. Singer.  Diet and iron status, a study of relationships: United States, 1971-74. Data from the National Health Survey. Series 11, No. 229. , 1982, Vital and health statistics. Series 11, Data from the National Health Survey.

[67]  I. Trowbridge,et al.  Murine cell surface transferrin receptor: Studies with an anti‐receptor monoclonal antibody , 1982, Journal of cellular physiology.

[68]  W. Pryor.  FREE RADICAL BIOLOGY: XENOBIOTICS, CANCER, AND AGING * , 1982, Annals of the New York Academy of Sciences.

[69]  Elizabeth C. Theil,et al.  Iron binding by horse spleen apoferritin. A vanadyl(IV) EPR spin probe study. , 1982, The Journal of biological chemistry.

[70]  S. Rockwell.  Cytotoxicities of mitomycin C and x rays to aerobic and hypoxic cells in vitro. , 1982, International journal of radiation oncology, biology, physics.

[71]  H. Watanabe,et al.  Induction and characterization of gastro-duodenal lesions in mice given continuous oral administration of hydrogen peroxide. , 1982, Gan.

[72]  E. Hall,et al.  Sensitizers, protectors and oncogenic transformation in vitro. , 1982, International journal of radiation oncology, biology, physics.

[73]  F. Lopez,et al.  Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Orrenius,et al.  Toxic injury to isolated hepatocytes is not dependent on extracellular calcium. , 1981, Science.

[75]  M. Greaves,et al.  Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[76]  J. Brock,et al.  Transferrin binding and iron uptake by mouse lymph node cells during transformation in response to concanavalin A. , 1981, Immunology.

[77]  H. Stich,et al.  Chromosome-damaging activity of ferritin and its relation to chelation and reduction of iron. , 1981, Cancer research.

[78]  R. Floyd.  DNA-ferrous iron catalyzed hydroxyl free radical formation from hydrogen peroxide. , 1981, Biochemical and biophysical research communications.

[79]  R. S. Johnson.  Hyperthermia, still experimental, may win place in cancer therapy. , 1981, JAMA.

[80]  J. Repine,et al.  Dimethyl sulfoxide prevents DNA nicking mediated by ionizing radiation or iron/hydrogen peroxide-generated hydroxyl radical. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[81]  L. Braby,et al.  Rapid repair of ionizing radiation injury in Chlamydomonas reinhardi. , 1980, Radiation research.

[82]  R. Cutler,et al.  Superoxide dismutase: correlation with life-span and specific metabolic rate in primate species. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[83]  C. J. Murray,et al.  An ecological interdependence of diet and disease? A study of infection in one tribe consuming two different diets. , 1980, The American journal of clinical nutrition.

[84]  D. Jameson,et al.  Time effects in molecular radiation Biology , 1980, Radiation and environmental biophysics.

[85]  B. Halliwell,et al.  Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. , 1979, The Biochemical journal.

[86]  B. Casto,et al.  Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts. , 1979, Cancer research.

[87]  H. Ragan,et al.  Body Iron Loss in Animals , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[88]  C. Greenstock,et al.  RADIATION ACTIVATION OF CARCINOGENS AND THE ROLE OF OH AND O2‐ , 1978, Photochemistry and photobiology.

[89]  C. Walsh,et al.  Mechanism and kinetics of iron release from ferritin by dihydroflavins and dihydroflavin analogues. , 1978, Biochemistry.

[90]  I. Fridovich,et al.  The biology and pathology of oxygen radicals. , 1978, Annals of internal medicine.

[91]  J. A. Fernandez-Pol.  Isolation and characterization of a siderophore-like growth factor from mutants of SV40-transformed cells adapted to picolinic acid , 1978, Cell.

[92]  K. S. Olsson,et al.  Preclinical hemochromatosis in a population on a high-iron-fortified diet. , 1978, JAMA.

[93]  W. Crosby.  The Safety of Iron-Fortified Food , 1978 .

[94]  Stefan Fischer,et al.  Transferrin Receptors in Developing Murine Erythroid Cells , 1977, British journal of haematology.

[95]  E. Morgan,et al.  The Role of Endocytosis in Transferrin Uptake by Reticulocytes and Bone Marrow Cells , 1977, British journal of haematology.

[96]  W. R. Adey,et al.  Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[97]  R. Willson.  METRONIDAZOLE AND IRON IN CANCER THERAPY , 1976, The Lancet.

[98]  H. Ragan.  Enhanced Plutonium Absorption in Iron-Deficient Mice 1 , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[99]  Hoekstra Wg.  Biochemical function of selenium and its relation to vitamin E. , 1975, Federation proceedings.

[100]  P. Nettesheim,et al.  Carcinogenic and cocarcinogenic effects of inhaled synthetic smog and ferric oxide particles. , 1975, Journal of the National Cancer Institute.

[101]  K. Rajagopalan,et al.  The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. , 1975, The Journal of clinical investigation.

[102]  M. Worwood,et al.  Ferritin in serum. Clinical and biochemical implications. , 1975, The New England journal of medicine.

[103]  F. Stenbäck,et al.  Magnesium oxide as carrier dust in benzo(a)pyrene-induced lung carcino-genesis in Syrian hamsters. , 1975, Journal of the National Cancer Institute.

[104]  G. Adams,et al.  Reactivity of the Hydroxyl Radical in Aqueous Solutions. , 1973 .

[105]  J. Rabani,et al.  PULSE RADIOLYTIC DETERMINATION OF pK FOR HYDROXYL IONIC DISSOCIATION IN WATER , 1964 .

[106]  D. R. Kalkwarf.  CHEMICAL PROTECTION FROM RADIATION EFFECTS , 1960 .

[107]  J. Larrick,et al.  Selective Inhibition of the Growth of Human Erythroid Bursts by Monoclonal Antibodies Against Transferrin or the Transferrin Receptor , 2005 .

[108]  B. Teicher,et al.  Some complexes of cobalt(III) and iron(III) are radiosensitizers of hypoxic EMT6 cells. , 1987, Radiation research.

[109]  C. Winterbourn.  The ability of scavengers to distinguish OH. production in the iron-catalyzed Haber-Weiss reaction: comparison of four assays for OH. , 1987, Free radical biology & medicine.

[110]  K. Cooksey,et al.  Calcium cyclotron resonance and diatom mobility. , 1987, Bioelectromagnetics.

[111]  D A Savitz,et al.  Leukemia and occupational exposure to electromagnetic fields: review of epidemiologic surveys. , 1987, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[112]  H. Seidel.  Effects of radiation and other influences on chemical lymphomagenesis. , 1987, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[113]  R. Ferrell,et al.  Human transferrin polymorphism. , 1987, Human heredity.

[114]  W. Nothdurft,et al.  The development of radiation late effects to the bone marrow after single and chronic exposure. , 1986, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[115]  A. Jacobs.  Ferritin: an interim review. , 1985, Current topics in hematology.

[116]  D. House,et al.  Effects of ELF (1-120 Hz) and modulated (50 Hz) RF fields on the efflux of calcium ions from brain tissue in vitro. , 1985, Bioelectromagnetics.

[117]  C. W. Mays,et al.  A proportional hazards analysis of bone sarcoma rates in German 224radium patients. , 1985, Strahlentherapie. Sonderbande.

[118]  C. Greenstock,et al.  Radiosensitizers as probes of DNA damage and cell killing. , 1985, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[119]  W. J. Lorenz,et al.  Report on the German Thorotrast Study. , 1985, Strahlentherapie. Sonderbande.

[120]  H. Watanabe,et al.  Correlation between induction of duodenal tumor by hydrogen peroxide and catalase activity in mice. , 1984, Gan.

[121]  E. Weinberg.  Iron withholding: a defense against infection and neoplasia. , 1984, Physiological reviews.

[122]  M. Woodcock,et al.  Glutathione depletion enhances the lifetime of oxygen-reactive radicals in mammalian cells. , 1984, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[123]  B. Ames,et al.  Dietary carcinogens and anti-carcinogens. , 1984, Journal of toxicology. Clinical toxicology.

[124]  E. Weinberg.  Iron in neoplastic disease. , 1983, Nutrition and cancer.

[125]  C. J. Gillespie,et al.  Radiation-Induced Events and Their Time Scale in Mammalian Cells , 1981 .

[126]  S. Larson,et al.  Common pathway for tumor cell uptake of gallium-67 and iron-59 via a transferrin receptor. , 1980, Journal of the National Cancer Institute.

[127]  P. Fitzpatrick,et al.  Human isoferritins in normal and disease states. , 1977, Seminars in hematology.

[128]  B. Giovanella.  Actions of Hyperthermia on Tumor Cells Cultured in vitro , 1977 .

[129]  M. Worwood.  The clinical biochemistry of iron. , 1977, Seminars in hematology.

[130]  J. Cook,et al.  Evaluation of the iron status of a population. , 1976, Blood.

[131]  W. Hoekstra.  Biochemical function of selenium and its relation to vitamin E. , 1975, Federation proceedings.

[132]  E. Brown,et al.  Structure and function of transferrin. , 1975, Progress in hematology.

[133]  J. Rabani,et al.  Absorption spectrum and decay kinetics of O2- and HO2 in aqueous solutions by pulse radiolysis , 1969 .

[134]  A. Boujnah.  [IRON METABOLISM]. , 1964, La Tunisie medicale.